JW Holdings Corporation (096760.KS)
KRW 3045.0
(0.0%)
KRW 3045.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 20.65 Billion KRW | -71.93% |
| 2022 | 73.59 Billion KRW | -65.16% |
| 2021 | 211.25 Billion KRW | 135.59% |
| 2020 | 89.66 Billion KRW | -45.25% |
| 2019 | 163.77 Billion KRW | -31.75% |
| 2018 | 239.95 Billion KRW | -4.88% |
| 2017 | 252.26 Billion KRW | 0.08% |
| 2016 | 252.05 Billion KRW | 59.64% |
| 2015 | 157.88 Billion KRW | -26.66% |
| 2014 | 215.27 Billion KRW | 101.97% |
| 2013 | 106.58 Billion KRW | -39.02% |
| 2012 | 174.78 Billion KRW | -16.87% |
| 2011 | 210.24 Billion KRW | -0.33% |
| 2010 | 210.93 Billion KRW | 10.07% |
| 2009 | 191.64 Billion KRW | 102.82% |
| 2008 | 94.48 Billion KRW | -29.04% |
| 2007 | 133.15 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 30.07 Billion KRW | 45.58% |
| 2024 Q2 | 60.13 Billion KRW | 99.96% |
| 2023 Q4 | 20.65 Billion KRW | -78.85% |
| 2023 Q3 | 97.65 Billion KRW | 42.99% |
| 2023 Q2 | 68.29 Billion KRW | -41.73% |
| 2023 FY | 20.65 Billion KRW | -71.93% |
| 2023 Q1 | 117.18 Billion KRW | 59.24% |
| 2022 Q2 | 253.59 Billion KRW | -1.77% |
| 2022 Q3 | 124.5 Billion KRW | -50.9% |
| 2022 Q4 | 73.59 Billion KRW | -40.89% |
| 2022 Q1 | 258.16 Billion KRW | 22.21% |
| 2022 FY | 73.59 Billion KRW | -65.16% |
| 2021 FY | 211.25 Billion KRW | 135.59% |
| 2021 Q3 | 116.72 Billion KRW | 1.68% |
| 2021 Q2 | 114.78 Billion KRW | 58.29% |
| 2021 Q1 | 72.51 Billion KRW | -19.13% |
| 2021 Q4 | 211.25 Billion KRW | 80.99% |
| 2020 Q4 | 89.66 Billion KRW | -42.18% |
| 2020 Q1 | 152.43 Billion KRW | -6.92% |
| 2020 FY | 89.66 Billion KRW | -45.25% |
| 2020 Q2 | 158.51 Billion KRW | 3.99% |
| 2020 Q3 | 155.07 Billion KRW | -2.17% |
| 2019 Q1 | 167.59 Billion KRW | -30.16% |
| 2019 Q3 | 167.44 Billion KRW | -5.58% |
| 2019 FY | 163.77 Billion KRW | -31.75% |
| 2019 Q2 | 177.33 Billion KRW | 5.81% |
| 2019 Q4 | 163.77 Billion KRW | -2.19% |
| 2018 Q4 | 239.95 Billion KRW | 23.74% |
| 2018 Q3 | 193.91 Billion KRW | 21.37% |
| 2018 Q2 | 159.76 Billion KRW | -39.11% |
| 2018 Q1 | 262.37 Billion KRW | 4.01% |
| 2018 FY | 239.95 Billion KRW | -4.88% |
| 2017 Q2 | 256.37 Billion KRW | -18.21% |
| 2017 Q4 | 252.26 Billion KRW | -26.34% |
| 2017 FY | 252.26 Billion KRW | 0.08% |
| 2017 Q3 | 342.45 Billion KRW | 33.58% |
| 2017 Q1 | 313.44 Billion KRW | 24.36% |
| 2016 Q3 | 294.98 Billion KRW | 63.32% |
| 2016 FY | 252.05 Billion KRW | 59.64% |
| 2016 Q1 | 133.06 Billion KRW | -15.72% |
| 2016 Q4 | 252.05 Billion KRW | -14.56% |
| 2016 Q2 | 180.62 Billion KRW | 35.74% |
| 2015 Q4 | 157.88 Billion KRW | 1.16% |
| 2015 FY | 157.88 Billion KRW | -26.66% |
| 2015 Q3 | 156.07 Billion KRW | -12.05% |
| 2015 Q2 | 177.46 Billion KRW | -11.67% |
| 2015 Q1 | 200.9 Billion KRW | -6.67% |
| 2014 Q4 | 215.27 Billion KRW | 1.17% |
| 2014 Q3 | 212.78 Billion KRW | 0.66% |
| 2014 FY | 215.27 Billion KRW | 101.97% |
| 2014 Q1 | 158.64 Billion KRW | 48.84% |
| 2014 Q2 | 211.39 Billion KRW | 33.25% |
| 2013 Q3 | 115.93 Billion KRW | -6.7% |
| 2013 Q4 | 106.58 Billion KRW | -8.06% |
| 2013 FY | 106.58 Billion KRW | -39.02% |
| 2013 Q1 | 144.48 Billion KRW | -17.33% |
| 2013 Q2 | 124.25 Billion KRW | -14.0% |
| 2012 FY | 174.78 Billion KRW | -16.87% |
| 2012 Q4 | 174.78 Billion KRW | 0.0% |
| 2011 Q3 | - KRW | 0.0% |
| 2011 Q1 | - KRW | 0.0% |
| 2011 Q2 | - KRW | 0.0% |
| 2011 FY | 210.24 Billion KRW | -0.33% |
| 2010 Q3 | - KRW | 0.0% |
| 2010 Q2 | - KRW | 0.0% |
| 2010 Q1 | - KRW | 0.0% |
| 2010 FY | 210.93 Billion KRW | 10.07% |
| 2009 Q3 | - KRW | 0.0% |
| 2009 Q1 | - KRW | 0.0% |
| 2009 FY | 191.64 Billion KRW | 102.82% |
| 2009 Q2 | - KRW | 0.0% |
| 2008 Q1 | - KRW | 0.0% |
| 2008 Q2 | - KRW | 0.0% |
| 2008 FY | 94.48 Billion KRW | -29.04% |
| 2008 Q3 | - KRW | 0.0% |
| 2007 Q3 | - KRW | 0.0% |
| 2007 FY | 133.15 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -51.446% |
| Dong-A Socio Holdings Co., Ltd. | 202.06 Billion KRW | 89.777% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | 30.858% |
| HANDOK Inc. | 123.78 Billion KRW | 83.311% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -4242.122% |
| Yuhan Corporation | 60.23 Billion KRW | 65.705% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | 87.248% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -20188.529% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | 74.817% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -3399.409% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -241.443% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -11.526% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -64.153% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -1192.015% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -51.446% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -17160.702% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | 82.928% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | 35.446% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -39.34% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | 31.142% |
| JW Pharmaceutical Corporation | 30 Billion KRW | 31.142% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -9334.252% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -3457.646% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | 58.326% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -364.001% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -51.446% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -8.565% |
| Daewoong pharmaceutical Co.,Ltd | 93.41 Billion KRW | 77.887% |
| JW Pharmaceutical Corporation | 30 Billion KRW | 31.142% |
| Yuhan Corporation | 60.23 Billion KRW | 65.705% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -96.736% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | 48.84% |
| Suheung Co., Ltd. | 74 Billion KRW | 72.087% |
| JW Pharmaceutical Corporation | 30 Billion KRW | 31.142% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -395.779% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -88.436% |
| CKD Bio Corp. | 69.43 Billion KRW | 70.248% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | 40.253% |
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -28.086% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -6627.541% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -9334.252% |
| Chong Kun Dang Holdings Corp. | 72.11 Billion KRW | 71.354% |
| Boryung Corporation | 151.7 Billion KRW | 86.384% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | 73.693% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -241.443% |
| JW Lifescience Corporation | 168 Million KRW | -12196.031% |